Sepsis & infection

A Transcriptomic Classifier Model Identifies High-Risk Endotypes in a Prospective Study of Sepsis in Uganda*

Crit Care MedPublished Prospective cohort study

Authors' conclusion

Sepsis endotypes derived in HICs share biological and clinical features with those identified in sub-Saharan Africa, with major differences in host-pathogen profiles.

Study context

Population
Adults hospitalized with suspected sepsis at a public referral hospital in Uganda
Participants
128 adults
Exposure
HIC-derived transcriptomic sepsis endotypes (SRS-1, SRS-2, SRS-3) assigned by 19-gene and 7-gene classifiers
  • SRS-1n = 30
  • SRS-2n = 92
  • SRS-3n = 6
Outcome
Endotype assignment by 19-gene classifier
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Observational data: associations, not effects.

Further findings

Mortality · 30 days — SRS-1
48.1%
Persons living with HIV in SRS-1
80.0% · 24 of 30
Mortality among patients assigned to SRS-3 by 7-gene classifier · 30 days
15.1% · 8
  • Mortality among patients assigned to SRS-3 by 7-gene classifier: 8/53

Persons living with HIV in SRS-1

Predominantly persons living with HIV with advanced immunosuppression and frequent tuberculosis

Mortality · 30 days

Differed significantly by endotype; highest in SRS-1

Agreement between 19-gene and 7-gene sepsis response signatures (SRS) assignments

Poor agreement (Cohen's kappa)
0.11

Mortality among patients assigned to SRS-3 by 7-gene classifier · 30 days

Patient stratification suboptimal with 7-gene classifier

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

A Transcriptomic Classifier Model Identifies High-Risk Endotypes in a Prospective Study of Sepsis in Uganda*. Crit Care Med. Published 7 August 2023. doi:10.1097/ccm.0000000000006023

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.